Harmeet Singh Bedi, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 3 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Good Samaritan Hospital · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
14 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bedi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A117625 · Current
Licensed to practise in California · since 2011 · expires 2027-03-31 · Baba Farid University of Health Sciences, Government Medical College, Patiala.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$84,245
Medicare paid this office $84,245 for 268 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 76 | $39,391 | $186 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 26 | $4,021 | $155 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 24 | $3,656 | $152 |
| Short return visit (20+ min) | 58 | $3,563 | $56 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 19 | $3,061 | $161 |
See all 20 services
| Critical care, first 30-74 minutes | 76 | $39,391 | $186 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 26 | $4,021 | $155 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 24 | $3,656 | $152 |
| Short return visit (20+ min) | 58 | $3,563 | $56 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 19 | $3,061 | $161 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 32 | $2,643 | $83 |
| Aspiration of initial secretion of lung airway using an endoscope | 65 | $2,596 | $40 |
| Short return visit (20+ min) | 23 | $2,099 | $84 |
| Review by radiologist of ct guidance for needle placement | 34 | $2,085 | $61 |
| Critical care, each additional 30 minutes | 12 | $2,044 | $93 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 36 | $1,987 | $55 |
| New patient visit (30+ min) | 29 | $1,979 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,900 | $70 |
| 3d radiographic procedure with computerized image postprocessing | 34 | $1,147 | $34 |
| Review by radiologist of ct guidance for needle placement | 11 | $676 | $61 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 11 | $574 | $52 |
| 3d radiographic procedure with computerized image postprocessing | 11 | $372 | $34 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 52 | $248 | $5 |
| Aspiration of initial secretion of lung airway using an endoscope | 11 | $119 | $11 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 11 | $16 | $1 |
Procedures Medicare counted
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Who their Medicare patients are
268 Original Medicare patients in 2024. Average age 74 · Under 65 9% · 85 and older 12% · Women 51% · Also on Medicaid 31% · Health risk score 2.55. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Cancer 43% · Coronary heart disease 40% · Diabetes 35% · Atrial fibrillation 34% · Chronic kidney disease 33% · COPD 33% · Heart failure 29% · Depression 21% · Stroke 19% · Dementia 12%.
The office billed $1,313,320, Medicare allowed $106,549 and paid $84,245; for 849 services of 39 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 268 | 849 | 74 | 2.55 | $1,313,320 | $84,245 |
| 2023 | 258 | 774 | 73 | 2.58 | $1,060,160 | $79,326 |
| 2022 | 378 | 1,262 | 73 | 2.31 | $1,509,603 | $113,592 |
| 2021 | 314 | 849 | 72 | 2.28 | $1,041,859 | $87,703 |
| 2020 | 277 | 752 | 70 | 2.15 | $946,306 | $78,292 |
| 2019 | 286 | 690 | 71 | 2.51 | $689,760 | $72,049 |
| 2018 | 315 | 807 | 71 | 2.59 | $654,503 | $67,842 |
| 2017 | 366 | 1,158 | 66 | 2.65 | $623,097 | $65,879 |
| 2016 | 117 | 249 | 65 | 3.20 | $154,154 | $15,060 |
| 2014 | 24 | 38 | 72 | 4.57 | $6,122 | $2,336 |
| 2013 | 14 | 21 | 69 | 3.06 | $4,103 | $1,685 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Critical care, first 30-74 minutes | 66 | $37,124 | $192 |
| Short return visit (20+ min) | 81 | $5,612 | $58 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 28 | $4,554 | $163 |
| Aspiration of initial secretion of lung airway using an endoscope | 75 | $3,447 | $44 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 25 | $3,352 | $134 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 32 | $2,719 | $85 |
| Aspiration of fluid from chest cavity using imaging guidance | 19 | $2,387 | $92 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 15 | $2,234 | $149 |
| Review by radiologist of ct guidance for needle placement | 33 | $2,122 | $64 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 37 | $2,023 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,386 | $73 |
| New patient visit (30+ min) | 18 | $1,288 | $72 |
| 3d radiographic procedure with computerized image postprocessing | 32 | $1,125 | $35 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 54 | $360 | $7 |
2022: 14 services
| Critical care, first 30-74 minutes | 72 | $35,914 | $195 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 53 | $8,464 | $160 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 49 | $7,975 | $163 |
| Short return visit (20+ min) | 108 | $7,464 | $57 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 76 | $6,566 | $86 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 83 | $5,930 | $71 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 35 | $5,521 | $158 |
| Review by radiologist of ct guidance for needle placement | 82 | $5,305 | $65 |
| Aspiration of initial secretion of lung airway using an endoscope | 135 | $4,730 | $31 |
| Aspiration of fluid from chest cavity using imaging guidance | 35 | $3,916 | $93 |
| New patient visit (30+ min) | 46 | $3,270 | $71 |
| 3d radiographic procedure with computerized image postprocessing | 80 | $2,833 | $35 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,123 | $94 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 105 | $331 | $3 |
2021: 15 services
| Critical care, first 30-74 minutes | 72 | $36,618 | $199 |
| Aspiration of fluid from chest cavity using imaging guidance | 41 | $6,361 | $101 |
| Short return visit (20+ min) | 79 | $6,129 | $61 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 21 | $3,964 | $189 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 25 | $3,798 | $152 |
| Aspiration of initial secretion of lung airway using an endoscope | 80 | $3,746 | $44 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 34 | $3,397 | $94 |
| New patient visit (30+ min) | 40 | $3,152 | $79 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 30 | $2,562 | $85 |
| Review by radiologist of ct guidance for needle placement | 36 | $2,396 | $67 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 12 | $1,946 | $162 |
| Return visit (30+ min) | 19 | $1,654 | $75 |
| Drainage of fluid from chest cavity with insertion of indwelling tube using imaging guidance | 12 | $1,584 | $122 |
| 3d radiographic procedure with computerized image postprocessing | 35 | $1,267 | $36 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 61 | $401 | $6 |
2020: 15 services
| Critical care, first 30-74 minutes | 25 | $12,201 | $203 |
| Long return visit (40+ min) | 60 | $7,333 | $92 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 44 | $6,813 | $139 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 27 | $5,957 | $221 |
| Aspiration of fluid from chest cavity using imaging guidance | 28 | $4,826 | $101 |
| Aspiration of initial secretion of lung airway using an endoscope | 84 | $4,106 | $45 |
| Return visit (30+ min) | 42 | $3,952 | $73 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,924 | $187 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 18 | $3,763 | $209 |
| New patient visit (60+ min) | 27 | $3,709 | $137 |
| Drainage of fluid from chest cavity with insertion of indwelling tube using imaging guidance | 18 | $2,783 | $133 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 15 | $1,834 | $115 |
| New patient visit (45+ min) | 16 | $1,809 | $113 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 85 | $1,578 | $17 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 13 | $1,168 | $90 |
2019: 16 services
| Long return visit (40+ min) | 93 | $13,530 | $95 |
| New patient visit (60+ min) | 62 | $8,854 | $143 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 49 | $8,392 | $129 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,817 | $182 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 18 | $4,029 | $224 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 80 | $3,551 | $35 |
| Aspiration of fluid from chest cavity | 33 | $2,948 | $78 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 16 | $2,930 | $183 |
| Long return visit (40+ min) | 22 | $2,096 | $87 |
| Drainage of fluid from chest cavity with insertion of indwelling tube | 15 | $1,826 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,792 | $94 |
| Aspiration of initial secretion of lung airway using an endoscope | 16 | $1,787 | $81 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 12 | $1,706 | $142 |
| New patient visit (60+ min) | 12 | $1,549 | $129 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 12 | $733 | $61 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $155 | $11 |
2018: 22 services
| Biopsy of lobe of lung using an endoscope, 1 lobe | 55 | $8,690 | $132 |
| New patient visit (60+ min) | 51 | $7,405 | $145 |
| Long return visit (40+ min) | 55 | $6,983 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,276 | $182 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 19 | $3,592 | $189 |
| Long return visit (40+ min) | 25 | $3,356 | $96 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 78 | $3,205 | $33 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 13 | $2,875 | $221 |
| Aspiration of fluid from chest cavity using imaging guidance | 20 | $2,814 | $97 |
| New patient visit (60+ min) | 14 | $1,928 | $138 |
| Diagnostic exam of lung airway using an endoscope | 13 | $1,536 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,498 | $94 |
| Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | 11 | $1,483 | $135 |
| Aspiration of initial secretion of lung airway using an endoscope | 25 | $1,186 | $40 |
| Computer-assisted image-guided navigation of lung airways using an endoscope | 12 | $1,036 | $86 |
| Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | 12 | $726 | $61 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 49 | $651 | $11 |
| Test to examine how well the lungs exchange gases | 43 | $353 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 24 | $283 | $12 |
| Test to measure expiratory airflow and volume | 26 | $197 | $8 |
| Test to measure expiratory airflow and volume | 12 | $91 | $8 |
| Exam of lung airways using an endoscope | 11 | $29 | $3 |
2017: 20 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,526 | $181 |
| Long return visit (40+ min) | 40 | $6,399 | $94 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 37 | $5,789 | $138 |
| New patient visit (60+ min) | 35 | $5,118 | $146 |
| Aspiration of fluid from chest cavity using imaging guidance | 31 | $3,859 | $99 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | 18 | $2,998 | $167 |
| Test to measure expiratory airflow and volume | 143 | $2,794 | $7 |
| Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | 12 | $2,542 | $212 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 63 | $2,536 | $34 |
| Drainage of fluid from chest cavity with insertion of indwelling tube using imaging guidance | 14 | $2,483 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,244 | $93 |
| Aspiration of initial secretion of lung airway using an endoscope | 25 | $2,042 | $76 |
| Long return visit (40+ min) | 12 | $1,668 | $93 |
| Diagnostic exam of lung airway using an endoscope | 11 | $1,659 | $118 |
| New patient visit (60+ min) | 12 | $1,630 | $136 |
| Test to examine how well the lungs exchange gases | 71 | $672 | $8 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 50 | $655 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 31 | $365 | $12 |
| Test to determine lung volumes using sensors | 21 | $233 | $11 |
| Test to measure expiratory airflow and volume | 11 | $83 | $8 |
2016: 6 services
| Aspiration of fluid from chest cavity using imaging guidance | 12 | $2,023 | $96 |
| New patient visit (60+ min) | 13 | $1,946 | $150 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 12 | $1,845 | $142 |
| Long return visit (40+ min) | 11 | $1,288 | $99 |
| Test to measure expiratory airflow and volume | 69 | $842 | $8 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 17 | $461 | $26 |
2014: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $814 | $58 |
Medicaid work
$5,757 in 2024
Medicaid paid $5,757 for 67 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 67 | $5,757 |
| 2024 | 67 | 1 | 13 | $5,757 |
| 2023 | 125 | 1 | 18 | $13,861 |
| 2022 | 167 | 1 | 19 | $18,990 |
| 2021 | 84 | 1 | 20 | $8,792 |
| 2018 | 26 | 2 | 14 | $131 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 125 | $13,861 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 167 | $18,990 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 84 | $8,792 |
2018
| Diffusing capacity | 14 | $71 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 12 | $60 |
Drugs they prescribed that Part D paid
$35,364
Pharmacies billed $35,364 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 105) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
44 generic and 61 brand-name prescriptions · $35,364 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Anoro Ellipta | 23 | $17,702 | $770 |
| Albuterol Sulfate Hfa | 27 | $1,509 | $56 |
Year by year
| 2024 | 105 | 22 | 0% (0) | 58% | $35,364 |
| 2023 | 152 | 36 | None | 70% | $60,150 |
| 2022 | 161 | 44 | None | 70% | $53,743 |
| 2021 | 165 | 36 | 0% (0) | 65% | $44,649 |
| 2020 | 195 | 41 | 0% (0) | 66% | $60,753 |
| 2019 | 199 | 48 | 0% (0) | 61% | $50,154 |
| 2018 | 118 | 36 | None | 58% | $19,641 |
| 2017 | 71 | 22 | None | 51% | $10,669 |
| 2016 | 36 | 14 | None | 56% | $48,815 |
| 2015 | 44 | 20 | None | 36% | $11,160 |
| 2014 | 85 | 13 | None | 51% | $16,156 |
| 2013 | 41 | 17 | None | None | $2,169 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Anoro Ellipta | 21 | $15,997 | $762 |
| Trelegy Ellipta | 11 | $10,213 | $928 |
| Stiolto Respimat | 12 | $8,731 | $728 |
| Spiriva Handihaler | 12 | $6,580 | $548 |
| Albuterol Sulfate Hfa | 21 | $1,064 | $51 |
2022: 8 drugs
| Anoro Ellipta | 20 | $11,928 | $596 |
| Trelegy Ellipta | 13 | $11,249 | $865 |
| Stiolto Respimat | 15 | $8,812 | $587 |
| Symbicort | 16 | $6,417 | $401 |
| Advair Diskus | 12 | $5,323 | $444 |
| Albuterol Sulfate Hfa | 23 | $1,442 | $63 |
| Montelukast | 11 | $216 | $20 |
| Prednisone | 15 | $73 | $5 |
2021: 6 drugs
| Anoro Ellipta | 16 | $11,422 | $714 |
| Symbicort | 13 | $5,154 | $396 |
| Advair Diskus | 12 | $5,043 | $420 |
| Stiolto Respimat | 11 | $4,871 | $443 |
| Albuterol Sulfate Hfa | 24 | $1,051 | $44 |
| Prednisone | 24 | $140 | $6 |
2020: 5 drugs
| Anoro Ellipta | 26 | $15,844 | $609 |
| Trelegy Ellipta | 20 | $12,543 | $627 |
| Symbicort | 16 | $7,185 | $449 |
| Spiriva | 12 | $6,311 | $526 |
| Prednisone | 15 | $63 | $4 |
2019: 6 drugs
| Trelegy Ellipta | 19 | $10,703 | $563 |
| Spiriva | 19 | $8,089 | $426 |
| Anoro Ellipta | 17 | $7,810 | $459 |
| Stiolto Respimat | 14 | $7,327 | $523 |
| Symbicort | 13 | $7,020 | $540 |
| Prednisone | 29 | $160 | $6 |
2018: 1 drug
| Levalbuterol Tartrate Hfa | 13 | $1,237 | $95 |
2017: 1 drug
| Advair Diskus | 16 | $5,776 | $361 |
2014: 3 drugs
| Spiriva | 11 | $5,126 | $466 |
| Advair Diskus | 14 | $4,235 | $302 |
| Montelukast | 11 | $425 | $39 |
Money from drug and device companies
$2,130 in 2025
| 2025 | 3 | 13 | None | $2,130 |
| 2024 | 2 | 11 | None | $2,988 |
| 2023 | 2 | 3 | None | $68 |
| 2022 | 2 | 5 | None | $237 |
| 2021 | 2 | 13 | None | $1,566 |
| 2019 | 2 | 2 | None | $32,563 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Intuitive Surgical | Da Vinci Surgical System | $1,829 | 10 payments
|
| Galvanize Therapeutics | Aliya System | $157 | 1 payment
|
| Ethicon | Monarch Platform | $144 | 2 payments
|
See all 13 published payments
| Intuitive Surgical | Meals · 2025-12-16 | Da Vinci Surgical System | $17 |
| Intuitive Surgical | Meals · 2025-12-16 | Da Vinci Surgical System | $46 |
| Intuitive Surgical | Meals · 2025-12-09 | Da Vinci Surgical System | $89 |
| Intuitive Surgical | Meals · 2025-12-09 | Da Vinci Surgical System | $12 |
| Intuitive Surgical | Meals · 2025-12-09 | Da Vinci Surgical System | $59 |
| Intuitive Surgical | Meals · 2025-12-09 | Da Vinci Surgical System | $28 |
| Ethicon | Meals · 2025-10-16 | Monarch Platform | $3 |
| Intuitive Surgical | Meals · 2025-10-14 | Da Vinci Surgical System | $26 |
| Galvanize Therapeutics | Meals · 2025-09-25 | Aliya System | $157 |
| Intuitive Surgical | Education · 2025-08-27 | Da Vinci Surgical System | $1,500 |
| Intuitive Surgical | Meals · 2025-08-19 | Da Vinci Surgical System | $30 |
| Intuitive Surgical | Meals · 2025-03-11 | Da Vinci Surgical System | $24 |
| Ethicon | Meals · 2025-02-12 | Monarch Platform | $140 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $2,988
| Intuitive Surgical | Da Vinci Surgical System | $2,808 | 10 payments
|
| Steris | Trufreeze | $180 | 1 payment
|
2023: $68
| Ethicon | Axert | $55 | 2 payments
|
| Pulmonx | Chartis Catheter | $13 | 1 payment
|
2022: $237
| Ethicon | Monarch Platform | $210 | 4 payments
|
| Ambu | None | $27 | 1 payment
|
2021: $1,566
| Intuitive Surgical | Da Vinci Surgical System | $1,055 | 5 payments
|
| Ethicon | Monarch Platform | $512 | 8 payments
|
2019: $32,563
| Genentech | None | $32,500 | 1 payment
|
| Covidien LP | Superdimension | $63 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Ethicon Endo-Surgery Inc. · A Propsective Multicenter Study of Transbronchial Microwave Ablation Using Robotic-Assisted Bronchoscopy in Patients With Oligometastatic Or Primary Tumors in the Lung · 2023 | Their institution | $78,057 |
| Ethicon Endo-Surgery Inc. · A Propsective Multicenter Study of Transbronchial Microwave Ablation Using Robotic-Assisted Bronchoscopy in Patients With Oligometastatic Or Primary Tumors in the Lung · 2024 | Their institution | $18,263 |
| Philips Electronics North America Corporation · Study To Evaluate Cerebral Aneurysmflow Results in Occlusion (Caro) · 2023 | Their institution | $8,000 |
| Ethicon Endo-Surgery Inc. · A Propsective Multicenter Study of Transbronchial Microwave Ablation Using Robotic-Assisted Bronchoscopy in Patients With Oligometastatic Or Primary Tumors in the Lung · 2025 | Their institution | $4,288 |
| Medtronic, Inc. · Atlas Study · 2022 | Their institution | $3,465 |
| Medtronic, Inc. · Atlas Study · 2021 | Their institution | $3,465 |
Professional record
- NPI
- 1548402084
- Licence
- CA A117625California A117625: Current · expires 2027-03-31
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Internal medicine (207R00000X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2009-03-30
- NPI last updated
- 2024-04-15
- NPI record certified
- 2024-04-15
This is when the NPI record was last certified, not a medical board exam.